Akèy › Sindrom Sjogren › Maryland
Etid klinik pou Sindrom Sjogren nan Maryland
6 etid pou Sindrom Sjogren ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07281456The Pathogenesis and Natural History of Sjogren's Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 16 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01425892Characterization of Diseases With Salivary Gland Involvement
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 4 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT02327884Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Arthritis and Rheumatism Associates, Rockville
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 27, 2026 · NCT07404865The Myelin Disorders Biorepository Project
- Kennedy Krieger Institute, Baltimore
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 23, 2025 · NCT03047369Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.